Your Health, We Care

Home > Photo Wall > Honor and qualification

Production approval for ritecitinib

Release date: 2024-07-10 15:28:38     Recommended: 158

10L1035_23 利特昔替尼 批文_00.jpg

LITFULO is a kinase inhibitor used to treat severe alopecia areata in adults and adolescents aged 12 and above. It is not recommended to use in combination with other JAK inhibitors, biological immune modulators, cyclosporin, or other potent immunosuppressants.

Company News

Research News

Drug news